37 results on '"Marcatili, Matteo"'
Search Results
2. Genetic determinants of coping, resilience and self-esteem in schizophrenia suggest a primary role for social factors and hippocampal neurogenesis
3. The rapid antidepressant effectiveness of repeated dose of intravenous ketamine and intranasal esketamine: A post-hoc analysis of pooled real-world data
4. Predicting outcome with Intranasal Esketamine treatment: A machine-learning, three-month study in Treatment-Resistant Depression (ESK-LEARNING)
5. Evolution of antipsychotic-induced extrapyramidal symptoms in patients with schizophrenia in the real-life: A 4-year follow-up naturalistic study
6. The psychopathological impact of the SARS-CoV-2 epidemic on subjects suffering from different mental disorders: An observational retrospective study
7. The use of esketamine in comorbid treatment resistant depression and obsessive compulsive disorder following extensive pharmacogenomic testing: a case report
8. Two-Injection Start Regimen of Long-Acting Aripiprazole in 133 Patients With Schizophrenia
9. The rapid antidepressant effectiveness of repeated dose of intravenous ketamine and intranasal esketamine: A post-hoc analysis of pooled real-world data
10. The Association between Blood SIRT1 and Ghrelin, Leptin, and Antibody Anti-Hypothalamus: A Comparison in Normal Weight and Anorexia Nervosa
11. Association Study of BDNF, SLC6A4, and FTO Genetic Variants with Schizophrenia Spectrum Disorders
12. Cortical Astrocyte Progenitors and Astrocytes from Human Pluripotent Stem Cells
13. Association of HTTLPR, BDNF, and FTO Genetic Variants with Completed Suicide in Slovakia
14. Clinical Markers of Panic and Generalized Anxiety Disorder: Overlapping Symptoms, Different Course and Outcome
15. Possible Use of Minocycline in Adjunction to Intranasal Esketamine for the Management of Difficult to Treat Depression following Extensive Pharmacogenomic Testing: Two Case Reports
16. Treating bipolar depression with esketamine: Safety and effectiveness data from a naturalistic multicentric study on esketamine in bipolar versus unipolar treatment‐resistant depression.
17. Sleep endophenotypes of schizophrenia: slow waves and sleep spindles in unaffected first-degree relatives
18. Augmentative Pharmacological Strategies in Treatment-Resistant Major Depression: A Comprehensive Review
19. The use of esketamine in comorbid treatment resistant depression and obsessive compulsive disorder following extensive pharmacogenomic testing: a case report
20. Prevention Plan for COVID-19 in a Psychiatric Long-term Care Rehabilitation Facility
21. Long-Term Efficacy of Intranasal Esketamine in Treatment-Resistant Major Depression: A Systematic Review
22. Management of COVID-19 Infection in a Psychiatric Long-term Care Rehabilitation Facility: Update From an Italian Experience.
23. Delirium in the 'young' covid-19 patient (<65 years): preliminary clinical indications [Il delirium nel paziente covid-19 'giovane' (<65 anni): Indicazioni cliniche preliminari]
24. Consultation psychiatry in COVID ‐19 patients: Lopinavir/ritonavir interactions with main psychiatric drugs
25. Human induced pluripotent stem cells technology in treatment resistant depression: novel strategies and opportunities to unravel ketamine's fast-acting antidepressant mechanisms
26. Human induced pluripotent stem cells technology in treatment resistant depression: novel strategies and opportunities to unravel ketamine’s fast-acting antidepressant mechanisms
27. Epsins Regulate Mouse Embryonic Stem Cell Exit from Pluripotency and Neural Commitment by Controlling Notch Activation
28. Human Induced Pluripotent Stem Cells (hiPSCs) in Schizophrenia: Modelling the Disease and the Treatment Response
29. Establishment of induced pluripotent stem cell (iPSC) line from an 8-year old female patient with ischemic Moyamoya disease
30. Generation and characterization of an induced pluripotent stem cell (iPSC) line from a patient with clozapine-resistant Schizophrenia
31. Establishment of induced pluripotent stem cell (iPSC) line from 55-year old male patient with hemorrhagic Moyamoya disease
32. Establishment of an induced pluripotent stem cell (iPSC) line from a patient with Clozapine-responder Schizophrenia
33. Sleep endophenotypes of schizophrenia: slow waves and sleep spindles in unaffected first-degree relatives.
34. Evolution of antipsychotic-induced extrapyramidal symptoms in patients with schizophrenia in the real-life: A 4-year follow-up naturalistic study
35. Epsins regulate mouse embryonic stem cell exit from pluripotency and neural commitment by controlling notch activation
36. [Ketamine's fast-acting antidepressant mechanisms: state of the art and new research perspectives].
37. [Delirium in the "young" covid-19 patient (<65 years): preliminary clinical indications].
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.